D(+)-Sucrose, min. 99.5%, Ph.Eur., 10 kg, plastic packaging.

Boc-Gly-OH, 97%, 500g

ETHYL 4-CHLORO-1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE, 97.0%, 250mg

2-(ISOBUTYLAMINO)ACETIC ACID, 95.0%, 500mg

(4R,4'R,5S,5'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole], 97%, 5g

2-(4-(2-(1-Isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid, 98%, 250mg

1,1-DIETHOXYHEXANE, 95%, 25g

Microliter syringe GASTIGHT® series 1700 Point type 3, 25 µl, 1702 RNR, 1 piece

5-Iodo-3-(trifluoromethyl)pyridin-2-amine, 97%, 5g

BENZYL 3-(TERT-BUTOXYCARBONYL)BENZYLCARBAMATE, 95.0%, 250mg

5-Fluoro-1h,2h,3h-pyrrolo[2,3-b]pyridine, 97%, 500mg

3,3-Dimethylbenzo[c][1,2]oxaborol-1(3H)-ol, 95.0%, 100mg

7-Amino-4-(methoxymethyl)coumarin, 97.0%, 1g